Renata PLC
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia. (NCT06531018) | Renata PLC | 2025-02-07 |
Track Renata PLC automatically
Every clearance here is in the API, with alerts when new ones post.